AllianceBernstein’s Applied Therapeutics APLT Stock Holding History

AllianceBernstein’s Portfolio APLT Stock Details APLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-100,840	Closed	-$49.3K	–	3238
2025 Q1	$49.3K	Hold	100,840	–	–	﹤0.01%	3133
2024 Q4	$86.3K	Hold	100,840	–	–	﹤0.01%	3139
2024 Q3	$857K	Buy	100,840 +70,570	+233%	+$416K	﹤0.01%	2398
2024 Q2	$141K	Buy	+30,270	New	+$143K	﹤0.01%	3079
2022 Q2	–	Sell	-12,500	Closed	-$26K	–	3263
2022 Q1	$26K	Hold	12,500	–	–	﹤0.01%	3210
2021 Q4	$112K	Sell	12,500 -900	-7%	-$11.8K	﹤0.01%	3178
2021 Q3	$222K	Hold	13,400	–	–	﹤0.01%	3058
2021 Q2	$278K	Buy	13,400 +2,000	+18%	+$37.9K	﹤0.01%	3042
2021 Q1	$214K	Sell	11,400 -1,700	-13%	-$36.7K	﹤0.01%	3035
2020 Q4	$288K	Buy	+13,100	New	+$273K	﹤0.01%	2874
2020 Q3	–	Sell	-13,900	Closed	-$502K	–	3158
2020 Q2	$502K	Buy	13,900 +4,800	+53%	+$201K	﹤0.01%	2603
2020 Q1	$297K	Buy	+9,100	New	+$368K	﹤0.01%	2625

Other funds holding APLT

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

AllianceBernstein's APLT Position: Q2 2025 in Review

AllianceBernstein sold out of Applied Therapeutics (APLT) in Q2 2025, closing a stake of 100,840 shares — an estimated $49.3K sold.

AllianceBernstein first reported a position in APLT in Q1 2020 and held it in 12 quarters. The position peaked at $857K in Q3 2024. 75 funds tracked by Wall St. Rank hold APLT as of Q2 2025.

AllianceBernstein reported no remaining Applied Therapeutics position as of Q2 2025 after selling out during the quarter.
AllianceBernstein sold 100,840 Applied Therapeutics shares in Q2 2025, an estimated $49.3K.
AllianceBernstein first reported a position in Applied Therapeutics in Q1 2020 and held it in 12 quarters.
AllianceBernstein's Applied Therapeutics position peaked at $857K in Q3 2024.
75 funds tracked by Wall St. Rank held Applied Therapeutics as of Q2 2025.

Based on AllianceBernstein's 13F filing for Q2 2025, filed 14 Aug 2025.